三项胰岛素抵抗替代指标可预测新发重性抑郁障碍:荷兰队列研究
该研究基于荷兰抑郁与焦虑研究(NESDA)601名无抑郁或焦虑障碍终生史的18-65岁成人,随访9年,发现甘油三酯-HDL比值、空腹血糖和腰围三项胰岛素抵抗替代指标较高均与重性抑郁障碍新发风险正相关。入组后2年内新发糖尿病前期亦与新发重性抑郁障碍正相关。
要点
- 甘油三酯-HDL比值、空腹血糖、腰围升高均预测9年内新发重性抑郁障碍。
- 入组后2年内新发糖尿病前期与新发重性抑郁障碍风险正相关。
- 上述指标或可用于胰岛素抵抗或代谢异常患者的重性抑郁风险评估。
核心结论
- 三项胰岛素抵抗替代指标在9年随访中正向预测无抑郁或焦虑障碍史成人的新发重性抑郁障碍。
- 入组至2年访视期间新发糖尿病前期与新发重性抑郁障碍正相关。
研究设计与样本
- NESDA多中心纵向研究,纳入601名18-65岁无抑郁或焦虑障碍终生史的参与者。
- 结局为新发重性抑郁障碍,采用DSM-IV标准定义,随访9年。
- 暴露包括甘油三酯-HDL比值、空腹血糖水平和腰围。
主要发现
- 甘油三酯-HDL比值较高与新发重性抑郁风险正相关(HR=1.89,95%CI=1.15,3.11)。
- 空腹血糖较高与新发重性抑郁风险正相关(HR=1.37,95%CI=1.05,1.77)。
- 腰围较高与新发重性抑郁风险正相关(HR=1.11,95%CI=1.01,1.21)。
- 入组后2年内新发糖尿病前期与新发重性抑郁障碍正相关(HR=2.66,95%CI=1.13,6.27)。
关键数值与推荐
- 高甘油三酯-HDL比值定义依据原文表述,未报告具体切点。
- 糖尿病前期依据空腹血糖水平判定,未报告具体切点。
- 高中心性肥胖切点为腰围≥100 cm。
- 入组后2年内新发高甘油三酯-HDL比值和高中心性肥胖与新发重性抑郁无关。
临床怎么用
- 对胰岛素抵抗或代谢异常患者,可结合甘油三酯-HDL比值、空腹血糖和腰围评估重性抑郁风险。
- 关注入组后2年内新发糖尿病前期者的重性抑郁风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Major depressive disorder is the leading cause of disability worldwide. Yet, there remain significant challenges in predicting new cases of major depression and devising strategies to prevent the disorder. An important first step in this process is identifying risk factors for the incidence of major depression. There is accumulating biological evidence linking insulin resistance, another highly prevalent condition, and depressive disorders. The objectives of this study were to examine whether three surrogate measures of insulin resistance (high triglyceride-HDL [high-density lipoprotein] ratio; prediabetes, as indicated by fasting plasma glucose level; and high central adiposity, as measured by waist circumference) at the time of study enrollment were associated with an increased rate of incident major depressive disorder over a 9-year follow-up period and to assess whether the new onset of these surrogate measures during the first 2 years after study enrollment was predictive of incident major depressive disorder during the subsequent follow-up period. METHODS: The Netherlands Study of Depression and Anxiety (NESDA) is a multisite longitudinal study of the course and consequences of depressive and anxiety disorders in adults. The study population comprised 601 NESDA participants (18-65 years old) without a lifetime history of depression or anxiety disorders. The study's outcome was incident major depressive disorder, defined using DSM-IV criteria. Exposure measures included triglyceride-HDL ratio, fasting plasma glucose level, and waist circumference. RESULTS: Fourteen percent of the sample developed major depressive disorder during follow-up. Cox proportional hazards models indicated that higher triglyceride-HDL ratio was positively associated with an increased risk for incident major depression (hazard ratio=1.89, 95% CI=1.15, 3.11), as were higher fasting plasma glucose levels (hazard ratio=1.37, 95% CI=1.05, 1.77) and higher waist circumference (hazard ratio=1.11 95% CI=1.01, 1.21). The development of prediabetes in the 2-year period after study enrollment was positively associated with incident major depressive disorder (hazard ratio=2.66, 95% CI=1.13, 6.27). The development of high triglyceride-HDL ratio and high central adiposity (cut-point ≥100 cm) in the same period was not associated with incident major depression. CONCLUSIONS: Three surrogate measures of insulin resistance positively predicted incident major depressive disorder in a 9-year follow-up period among adults with no history of depression or anxiety disorder. In addition, the development of prediabetes between enrollment and the 2-year study visit was positively associated with incident major depressive disorder. These findings may have utility for evaluating the risk for the development of major depression among patients with insulin resistance or metabolic pathology.
引用
- Watson KT, Simard JF, Henderson VW, et al. Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry. 2021. PMID: 34551583. doi:10.1176/appi.ajp.2021.20101479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。